This study is a prospective, noninteractive, observational, and longitudinal study aimed at assessing the treatment pattern and clinical outcome of acromegaly in China.
Be able and willing to sign the informed consent form (ICF)
Male, female, age 18-75 years old (including 18 years old and 75 years old).
At least one laboratory or medical record shows that the patient is random GH ≥ 2.5 μg / L
At least one checklist or medical record shows radiographic evidence that the patient has a pituitary tumor
Ectopic secretion of GH or pituitary cancer
The patient is diagnosed with other complicated malignancies, or has previously been diagnosed with another malignancy, and there is currently evidence of lesion residue.
Have a diagnosis of other severe acute or chronic medical or psychiatric conditions that may increase the risk associated with study participation or may interfere with the interpretation of the study results and, in the judgement of the Investigator, would make the patient inappropriate for enrollment in this study.
Be a patient who, in the judgement of the Investigator, would be inappropriate for enrollment in this study